Legal Representation
Attorney
STEVEN A. ABREU
USPTO Deadlines
Application History
33 eventsDate | Code | Type | Description |
---|---|---|---|
Feb 7, 2011 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED |
Feb 7, 2011 | MAB6 | O | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED |
Jul 13, 2010 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Jul 12, 2010 | EX5G | S | SOU EXTENSION 5 GRANTED |
Jul 8, 2010 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
Jul 8, 2010 | EXT5 | S | SOU EXTENSION 5 FILED |
Jan 11, 2010 | EX4G | S | SOU EXTENSION 4 GRANTED |
Jan 7, 2010 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
Jan 7, 2010 | EXT4 | S | SOU EXTENSION 4 FILED |
Nov 24, 2009 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
Jul 28, 2009 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
Jul 28, 2009 | EX3G | S | SOU EXTENSION 3 GRANTED |
Jul 6, 2009 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
Jul 6, 2009 | EXT3 | S | SOU EXTENSION 3 FILED |
Dec 22, 2008 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
Dec 22, 2008 | EXT2 | S | SOU EXTENSION 2 FILED |
Dec 22, 2008 | EX2G | S | SOU EXTENSION 2 GRANTED |
Jul 7, 2008 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
Jul 7, 2008 | EXT1 | S | SOU EXTENSION 1 FILED |
Jul 7, 2008 | EX1G | S | SOU EXTENSION 1 GRANTED |
Jan 8, 2008 | NOAM | O | NOA MAILED - SOU REQUIRED FROM APPLICANT |
Oct 16, 2007 | PUBO | A | PUBLISHED FOR OPPOSITION |
Sep 26, 2007 | NPUB | O | NOTICE OF PUBLICATION |
Sep 11, 2007 | ALIE | A | ASSIGNED TO LIE |
Sep 11, 2007 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED |
Aug 2, 2007 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
Aug 1, 2007 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Aug 1, 2007 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Aug 1, 2007 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
Feb 2, 2007 | DOCK | D | ASSIGNED TO EXAMINER |
Feb 2, 2007 | CPRA | R | PRIORITY ACTION WRITTEN |
Feb 2, 2007 | GPRA | F | PRIORITY ACTION E-MAILED |
Sep 18, 2006 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 005
Pharmaceutical preparations for the treatment of viral diseases, cancer, cystic fibrosis, and inflammation
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005